ARA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ARA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
American Renal Associates Holdings's change in inventory for the quarter that ended in Sep. 2020 was $0.2 Mil. It means American Renal Associates Holdings's inventory declined by $0.2 Mil from Jun. 2020 to Sep. 2020 .
American Renal Associates Holdings's change in inventory for the fiscal year that ended in Dec. 2019 was $3.7 Mil. It means American Renal Associates Holdings's inventory declined by $3.7 Mil from Dec. 2018 to Dec. 2019 .
American Renal Associates Holdings's Total Inventories for the quarter that ended in Sep. 2020 was $7.6 Mil.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory. American Renal Associates Holdings's Days Inventory for the quarter that ended in Sep. 2020 was 4.79.
Inventory Turnover measures how fast the company turns over its inventory within a year. American Renal Associates Holdings's Inventory Turnover for the quarter that ended in Sep. 2020 was 19.04.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. American Renal Associates Holdings's Inventory-to-Revenue for the quarter that ended in Sep. 2020 was 0.04.
The historical data trend for American Renal Associates Holdings's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
American Renal Associates Holdings Annual Data | |||||||||||||||||
Trend | Dec12 | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | |||||||||
Change In Inventory | Get a 7-Day Free Trial | 0.54 | -0.39 | 0.01 | -6.80 | 3.66 |
American Renal Associates Holdings Quarterly Data | ||||||||||||||||||||
Dec15 | Mar16 | Jun16 | Sep16 | Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | |
Change In Inventory | Get a 7-Day Free Trial | -0.49 | 0.13 | 0.17 | -0.58 | 0.15 |
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Sep. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
American Renal Associates Holdings (NYSE:ARA) Change In Inventory Explanation
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
American Renal Associates Holdings's Days Inventory for the quarter that ended in is calculated as:
Days Inventory | = | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period |
= | 7.895 | / | 150.357 | * | 365 / 4 | |
= | 4.79 |
2. Inventory Turnover measures how fast the company turns over its inventory within a year.
American Renal Associates Holdings's Inventory Turnover for the quarter that ended in Sep. 2020 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 150.357 | / | 7.895 | |
= | 19.04 |
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
American Renal Associates Holdings's Inventory to Revenue for the quarter that ended in Sep. 2020 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 7.895 | / | 209.689 | |
= | 0.04 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of American Renal Associates Holdings's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Don E Williamson | officer: EVP, Chief Operating Officer | 500 CUMMINGS CENTER, SUITE 6550 BEVERLY MA 01915 |
Victoria Labriola | officer: VP and General Counsel | AMERICAN RENAL HOLDINGS, INC. 500 CUMMINGS CENTER, SUITE 6550 BEVERLY MA 01915 |
Joseph A Carlucci | director, officer: Chief Executive Officer | C/O AMERICAN RENAL ASSOCIATES HOLDINGS 500 CUMMINGS CENTER BEVERLY MA 01915 |
Syed T Kamal | director, officer: President | C/O AMERICAN RENAL ASSOCIATES HOLDINGS 500 CUMMINGS CENTER BEVERLY MA 01915 |
Jeremy Gelber | director | C/O CENTERBRIDGE PARTNERS, L.P., 375 PARK AVE, 12TH FLOOR, NEW YORK NY 10152 |
Christopher J Hocevar | director | 1601 CHESTNUT STREET SHAREHOLDER SERVICES TL05Y PHILADELPHIA PA 19192 |
Robert H Fish | director | C/O SKILLED HEALTHCARE 27442 PORTOLA PARKWAY, SUITE 200 FOOTHILL RANCH CA 92610 |
Michael Boxer | director | 9151 BOULEVARD 26 NORTH RICHLAND HILLS TX 76180 |
John M Jureller | director | FRONTIER COMMUNICATIONS, 401 MERRITT 7, NORWALK CT 06851 |
Thomas W Erickson | director | OMEGA HEALTHCARE INVESTORS INC, 900 VICTORS WAY STE. 350, AMM ARBER MI 48108 |
Jason Boucher | officer: Former VP & CFO | 500 CUMMINGS CENTER SUITE 6550 BEVERLY MA 01915 |
Mark Herbers | officer: Interim CFO and Interim CAO | 500 CUMMINGS CENTER, SUITE 6550, BEVERLY MA 01915 |
Michael Ray Costa | officer: VP and General Counsel | C/O AMERICAN RENAL ASSOCIATES HOLDINGS 500 CUMMINGS CENTER BEVERLY MA 01915 |
Patrick T Ryan | director | 401 EDGEWATER PLACE, SUITE 500, WAKEFIELD MA 01880 |
Jonathan L Wilcox | officer: VP & Chief Financial Officer | C/O AMERICAN RENAL ASSOCIATES HOLDINGS 500 CUMMINGS CENTER BEVERLY MA 01915 |
From GuruFocus
By Business Wire Business Wire • 08-04-2020
By Marketwired Marketwired • 08-06-2019
By Marketwired Marketwired • 05-28-2019
By Business Wire Business Wire • 01-26-2021
By Marketwired Marketwired • 10-15-2020
By Marketwired Marketwired • 07-31-2019
By PRNewswire PRNewswire • 10-02-2020
By PRNewswire PRNewswire • 10-02-2020
By ACCESSWIRE ACCESSWIRE • 10-05-2020
By Marketwired Marketwired • 12-02-2020
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.